MedTrace Logo

Efficacy of Pentoxifylline on Chronic Kidney Disease

NCT00155246 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2010-01-29

No results posted yet for this study

Summary

To study whether pentoxifylline has additive renoprotective effect in patients taking ARB

Conditions

Interventions

DRUG

pentoxifylline (drug)

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Tun-Jun Tsai, MD, PhD · National Taiwan University Hosptial

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-07-31
Primary Completion
2006-07-31
Completion
2007-01-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00155246 on ClinicalTrials.gov